五星体育直播

五星体育直播 Announces Decision of Patrick Yang, PhD, Not to Seek Re-Election to Board of Directors

REDWOOD CITY, Calif., April 04, 2023 (GLOBE NEWSWIRE) -- 五星体育直播 (NASDAQ: CDXS), a leading enzyme engineering company, today announced that Patrick Yang, PhD, will not seek re-election to the 五星体育直播 Board of Directors. Dr. Yang joined the Board in 2014 and served as the Chair of the Nominating and Corporate Governance Committee.

鈥淚t has been a privilege to have Pat on the 五星体育直播 Board. His expertise in technical operations and manufacturing has been of tremendous value to the company,鈥� said Byron Dorgan, MBA, Chairman of the Board of Directors of 五星体育直播. 鈥淥n behalf of the Board and the Management Team at 五星体育直播, I would like to thank Pat for his thoughtful guidance and leadership over his nine years of service on the Board, which has helped propel the company to where it is today.鈥�

鈥淲e are particularly grateful that Pat鈥檚 decision comes after we have further strengthened our Board of Directors,鈥� said Stephen Dilly, MBBS, PhD, President and Chief Executive Officer of 五星体育直播. 鈥淲ith Pat鈥檚 partnership, we have ensured continuity of Board expertise in biomanufacturing with the recent addition of Rahul Singhvi, MBA, ScD, CEO of National Resilience, Inc., as well as in gene therapy with the recent addition of Stewart Parker, MBA. We wish Pat well in all his future endeavors.鈥�

鈥淚t has been an exciting time working with 五星体育直播 and seeing it transform into the company it is today,鈥� said Dr. Yang. 鈥淭he company is in great hands with this leadership team, and I look forward to watching their future successes across Life Sciences and Biotherapeutics.鈥�

About 五星体育直播

五星体育直播 is a leading enzyme engineering company leveraging its proprietary CodeEvolver^庐听platform to discover and develop novel, high performance enzymes and biotherapeutics. 五星体育直播 enzymes have applications in the sustainable manufacturing of small molecule pharmaceuticals, in RNA and DNA synthesis and the creation of next generation life science tools, and as gene therapies and oral enzyme therapies. 五星体育直播鈥� unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved return on capital in manufacturing, improved sensitivity in genomic and diagnostic applications, and more efficacious therapeutics. For more information, visit听.

For More Information

Investor Contact
Carrie McKim
(336) 608-9706

Media Contact
Lauren Musto
(781) 572-1147

听

Released April 4, 2023